Fludarabine phosphate for the treatment of low grade lymphoid malignancy.

Thirty-four patients with previously treated, advanced, low grade NHL were treated with Fludarabine, a deamination-resistant analogue of adenosine arabinoside, at a dose of 25 mg m-2 intravenously, daily for 5 days (median number of cycles = 3, range 1-10). Complete remission (CR) was achieved in si...

Descripción completa

Detalles Bibliográficos
Autores principales: Whelan, J. S., Davis, C. L., Rule, S., Ranson, M., Smith, O. P., Mehta, A. B., Catovsky, D., Rohatiner, A. Z., Lister, T. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977289/
https://www.ncbi.nlm.nih.gov/pubmed/1713049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977289/
https://www.ncbi.nlm.nih.gov/pubmed/1713049

Ejemplares similares